Unknown Origin & Other Cancer Types

Genomic Screening can Help Detect Medullary Thyroid Cancer, Study Finds

Population-based genomic screening facilitates early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene.

Unknown Origin & Other Cancer Types

Viome Life Sciences Unveils Test for Oral & Throat Cancer Detection

Viome Life Sciences, a biotechnology company, unveiled its CancerDetect test for oral & throat cancer, the first launch in a series of diagnostic tests in development.

Unknown Origin & Other Cancer Types

Novel Assay for Early Detection of Ovarian Cancer Outperforms CA125, Research Shows

Mercy BioAnalytics' Mercy Halo Ovarian Cancer assay outperformed CA125 when identifying those with early high-grade serious ovarian cancer.

Handheld Device Could Painlessly Identify Skin Cancers

May 5, 2022 | Diagnostic Technologies, Unknown Origin & Other Cancer Types

Researchers are developing a low-cost handheld device that could cut the rate of unnecessary skin biopsies in half.

Can a Blood Test Help Spot Skin Cancer?

May 4, 2022 | Unknown Origin & Other Cancer Types

Research indicates that testing an individual’s blood can reveal the presence of circulating melanoma cells, indicating skin cancer.

Brain Tumor Diagnosis Is Changing Due to Genomic Sequencing

Apr 29, 2022 | Sequencing Systems, Unknown Origin & Other Cancer Types

A study by UC San Francisco underscores the critical role of genomic profiling in brain tumor diagnosis and grading.

Urine Test for Bladder Cancer Could Cut Need for Cystoscopies

Apr 25, 2022 | Unknown Origin & Other Cancer Types, Urinalysis & Toxicology

Researchers have developed a new urine test for bladder cancer, which could significantly cut the need for invasive cystoscopies.

New PCR Test Can Diagnose and Treat Oral Cancer

Apr 13, 2022 | Unknown Origin & Other Cancer Types

Researchers have developed a PCR test for mouth cancer, which only requires machines used in COVID testing and a technician to operate it.

Forgetting the Lab Has Consequences

Mar 14, 2022 | Microscopy, Tissue Processing, Unknown Origin & Other Cancer Types

Learn how CLP’s editor discovered firsthand how clinical laboratories and laboratorians are being taken for granted.

Cerebrospinal Fluid May be able to Identify Aggressive Brain Tumors in Children

Mar 3, 2022 | Unknown Origin & Other Cancer Types

It may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid, according to new research.

Circulating Tumor DNA Test Predicts Recurrence of Oropharyngeal Cancer Post-Treatment

Feb 25, 2022 | Unknown Origin & Other Cancer Types

Blood tests for the detection of circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment.

Liquid Biopsies Streamline Testing for Cancer Related to HPV

Dec 3, 2021 | Clinical Chemistry Analyzers, Unknown Origin & Other Cancer Types

Researchers developed a blood test for head and neck cancer associated with HPV that was shown to be more accurate and faster than conventional testing.

Genetic Markers for Liver Cancer Found in Blood and Saliva

Nov 26, 2021 | Molecular Diagnostics, Unknown Origin & Other Cancer Types

Researchers examined markers of liver cancer and found that the disease can be recognized by RNA fragments in saliva and blood.

First Results of AI-Based Pathology Diagnostic Tool for Gastric Cancer Announced

Nov 26, 2021 | Digital Imaging, Unknown Origin & Other Cancer Types

The results of research to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were recently announced.

Gene Mapping: Multiplex Network Improves Diagnosis, Analysis of Rare Diseases

Nov 15, 2021 | Emerging & Zoonotic Diseases, Sequencing Systems, Unknown Origin & Other Cancer Types

Researchers have developed a mulitiplex network that reveals underlying mechanisms of rare diseases for more accurate identification of genetic defects.

Genetic Testing Could Reduce Rare Pediatric Cancer Deaths by Half

Oct 28, 2021 | Sequencing Systems, Unknown Origin & Other Cancer Types

Genetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by about 50%, an NIH-funded analysis suggests.